Page last updated: 2024-11-07

dichlororibofuranosylbenzimidazole and Cancer of Stomach

dichlororibofuranosylbenzimidazole has been researched along with Cancer of Stomach in 2 studies

Dichlororibofuranosylbenzimidazole: An RNA polymerase II transcriptional inhibitor. This compound terminates transcription prematurely by selective inhibition of RNA synthesis. It is used in research to study underlying mechanisms of cellular regulation.

Research Excerpts

ExcerptRelevanceReference
"Treatment of human gastric cancer TMK-1 cells with transcription and translation inhibitors rapidly triggered cell apoptosis."1.30Dexamethasone suppresses apoptosis in a human gastric cancer cell line through modulation of bcl-x gene expression. ( Chang, TC; Chu, JT; Chu, LL; Hung, MW; Jiang, SY; Tsai, LC, 1997)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chang, TC2
Hung, MW2
Jiang, SY1
Chu, JT1
Chu, LL1
Tsai, LC2
Lin, YL1
Chen, YH1
Chang, GG1

Other Studies

2 other studies available for dichlororibofuranosylbenzimidazole and Cancer of Stomach

ArticleYear
Dexamethasone suppresses apoptosis in a human gastric cancer cell line through modulation of bcl-x gene expression.
    FEBS letters, 1997, Sep-22, Volume: 415, Issue:1

    Topics: Apoptosis; bcl-X Protein; Cycloheximide; Dactinomycin; Dexamethasone; Dichlororibofuranosylbenzimida

1997
Differential regulation of placental and germ cell alkaline phosphatases by glucocorticoid and sodium butyrate in human gastric carcinoma cell line TMK-1.
    Archives of biochemistry and biophysics, 2001, Apr-01, Volume: 388, Issue:1

    Topics: Alkaline Phosphatase; Blotting, Northern; Butyrates; Dexamethasone; Dichlororibofuranosylbenzimidazo

2001